Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Jul 5 REGN Swing Trading Regeneron Stock Shows How To Bob And Weave
Jul 5 AUPH Aurinia Pharmaceuticals Appears Undervalued
Jul 5 REGN Dupixent “addresses current gap” in COPD biologics landscape
Jul 5 SVRA Savara Inc.'s (NASDAQ:SVRA) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week
Jul 4 SRPT Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News?
Jul 3 SRPT 1 Soaring Growth Stock to Buy and Hold for 10 Years
Jul 3 SRPT Best Momentum Stocks to Buy for July 3rd
Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 REGN Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3 REGN Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3 REGN Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Jul 2 REGN Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
Jul 2 REGN Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
Jul 2 NBIX FDA grants priority review for Neurocrine’s crinecerfont NDAs
Jul 1 NBIX FDA sets target action dates for Neurocrine drug applications
Jul 1 REGN Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
Jul 1 NBIX Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult Patients with CAH
Jun 30 SVRA Did Savara Inc. (SVRA) Receive a Good Rating from Wall Street Analysts in Q1?
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags